Evidence map›Paper›PMID 39095474›Full record

ArticleScientific reports2024

Deep learning predicts the 1-year prognosis of pancreatic cancer patients using positive peritoneal washing cytology.

Aya Noguchi, Yasushi Numata, Takanori Sugawara, Hiroshu Miura, Kaori Konno, Yuzu Adachi, Ruri Yamaguchi, Masaharu Ishida, Takashi Kokumai, Daisuke Douchi and 13 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Review
  3. Explainable Lightweight Model Using Low-Rank and Convolutional Block Attention for Pancreatic Cancer Diagnosis.The international journal of medical robotics + computer assisted surgery : MRCAS · 2026
    Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Aya NoguchiDepartment of Surgery, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
Yasushi NumataPathology Informatics Team, RIKEN Center for Advanced Intelligence Project, Nihonbashi 1-chome Mitsui Bldg. 15F, 1-4-1 Nihonbashi, Chuo-ku, Tokyo, 103-0027, Japan.
Takanori SugawaraDepartment of Pathology, Tohoku University Hospital, Sendai, 980-8574, Japan.
Hiroshu MiuraDepartment of Pathology, Tohoku University Hospital, Sendai, 980-8574, Japan.
Kaori KonnoDepartment of Pathology, Tohoku University Hospital, Sendai, 980-8574, Japan.
Yuzu AdachiDepartment of Pathology, Tohoku University Hospital, Sendai, 980-8574, Japan.
Ruri YamaguchiDepartment of Investigative Pathology, Tohoku University Graduate School of Medicine, 2-1 Seiryomachi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.
Masaharu IshidaDepartment of Surgery, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
Takashi KokumaiDepartment of Surgery, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
Daisuke DouchiDepartment of Surgery, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
Takayuki MiuraDepartment of Surgery, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
Kyohei AriakeDepartment of Surgery, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
Shun NakayamaDepartment of Surgery, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
Shimpei MaedaDepartment of Surgery, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
Hideo OhtsukaDepartment of Surgery, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
Masamichi MizumaDepartment of Surgery, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
Kei NakagawaDepartment of Surgery, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
Hiromu MorikawaPathology Informatics Team, RIKEN Center for Advanced Intelligence Project, Nihonbashi 1-chome Mitsui Bldg. 15F, 1-4-1 Nihonbashi, Chuo-ku, Tokyo, 103-0027, Japan.
Jun AkatsukaPathology Informatics Team, RIKEN Center for Advanced Intelligence Project, Nihonbashi 1-chome Mitsui Bldg. 15F, 1-4-1 Nihonbashi, Chuo-ku, Tokyo, 103-0027, Japan.
Ichiro MaedaPathology Informatics Team, RIKEN Center for Advanced Intelligence Project, Nihonbashi 1-chome Mitsui Bldg. 15F, 1-4-1 Nihonbashi, Chuo-ku, Tokyo, 103-0027, Japan.
Michiaki UnnoDepartment of Surgery, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
Yoichiro YamamotoPathology Informatics Team, RIKEN Center for Advanced Intelligence Project, Nihonbashi 1-chome Mitsui Bldg. 15F, 1-4-1 Nihonbashi, Chuo-ku, Tokyo, 103-0027, Japan. yoichiro.yamamoto@riken.jp.
Toru FurukawaDepartment of Investigative Pathology, Tohoku University Graduate School of Medicine, 2-1 Seiryomachi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan. toru.furukawa@med.tohoku.ac.jp.

Funding

JST Moonshot R&D JPMJMS2022
6 · The paper itself

Abstract

Peritoneal washing cytology (CY) in patients with pancreatic cancer is mainly used for staging; however, it may also be used to evaluate the intraperitoneal status to predict a more accurate prognosis. Here, we investigated the potential of deep learning of CY specimen images for predicting the 1-year prognosis of pancreatic cancer in CY-positive patients. CY specimens from 88 patients with prognostic information were retrospectively analyzed. CY specimens scanned by the whole slide imaging device were segmented and subjected to deep learning with a Vision Transformer (ViT) and a Convolutional Neural Network (CNN). The results indicated that ViT and CNN predicted the 1-year prognosis from scanned images with accuracies of 0.8056 and 0.8009 in the area under the curve of the receiver operating characteristic curves, respectively. Patients predicted to survive 1 year or more by ViT showed significantly longer survivals by Kaplan-Meier analyses. The cell nuclei found to have a negative prognostic impact by ViT appeared to be neutrophils. Our results indicate that AI-mediated analysis of CY specimens can successfully predict the 1-year prognosis of patients with pancreatic cancer positive for CY. Intraperitoneal neutrophils may be a novel prognostic marker and therapeutic target for CY-positive patients with pancreatic cancer.

Indexed as

Deep LearningPancreatic NeoplasmsAdultAgedAged, 80 and overCytodiagnosisFemaleHumansKaplan-Meier EstimateMaleMiddle AgedNeural Networks, ComputerNeutrophilsPeritoneal LavagePrognosisRetrospective Studies

Identifiers

PMID39095474
PMCPMC11297136

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.